当前位置:首页 - 行情中心 - 力生制药(002393) - 财务分析 - 现金流量表

力生制药

(002393)

  

流通市值:51.87亿  总市值:53.35亿
流通股本:2.50亿   总股本:2.58亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,008,713,306.08673,934,084.11285,497,465.111,270,340,223.86
  收到的税费返还15,589.0615,589.0615,589.064,402,169.24
  收到其他与经营活动有关的现金113,108,957.1691,600,684.5925,372,994.1193,592,769.07
  经营活动现金流入小计1,121,837,852.3765,550,357.76310,886,048.281,368,335,162.17
  购买商品、接受劳务支付的现金278,438,685.88187,109,163.897,027,390.25441,216,326.16
  支付给职工以及为职工支付的现金188,895,414.86127,605,321.3173,822,258.16279,858,336.58
  支付的各项税费160,625,209.47120,308,589.8236,839,325.91158,510,624.56
  支付其他与经营活动有关的现金369,058,945.53260,696,456.71104,174,685.54400,486,518.46
  经营活动现金流出小计997,018,255.74695,719,531.64311,863,659.861,280,071,805.76
  经营活动产生的现金流量净额124,819,596.5669,830,826.12-977,611.5888,263,356.41
二、投资活动产生的现金流量:
  收回投资收到的现金2,310,230,0001,934,975,0001,243,674,0001,942,396,660.43
  取得投资收益收到的现金39,226,845.8513,074,424.346,118,675.8240,430,198.09
  处置固定资产、无形资产和其他长期资产收回的现金净额43,442.0837,442.0826,553.28411,679.29
  处置子公司及其他营业单位收到的现金净额00--
  收到的其他与投资活动有关的现金50,000,00050,000,000-16,429,914.8
  投资活动现金流入小计2,399,500,287.931,998,086,866.421,249,819,229.11,999,668,452.61
  购建固定资产、无形资产和其他长期资产支付的现金17,353,946.9412,173,916.335,456,430.3753,750,773.71
  投资支付的现金2,725,230,0002,269,975,0001,143,674,0002,205,005,000
  取得子公司及其他营业单位支付的现金6,991,855---
  支付其他与投资活动有关的现金12,50013,281.0912,500-
  投资活动现金流出小计2,749,588,301.942,282,162,197.421,149,142,930.372,258,755,773.71
  投资活动产生的现金流量净额-350,088,014.01-284,075,331100,676,298.73-259,087,321.1
三、筹资活动产生的现金流量:
  吸收投资收到的现金61,104,30061,104,30061,104,300-
  取得借款收到的现金25,000,00010,000,000-39,750,000
  收到其他与筹资活动有关的现金1,052,017.971,052,017.97--
  筹资活动现金流入小计87,156,317.9772,156,317.9761,104,30039,750,000
  偿还债务支付的现金39,750,00039,750,00010,000,00047,192,994.13
  分配股利、利润或偿付利息支付的现金97,437,481.6192,804,490.88704,431.61121,029,338.78
  支付其他与筹资活动有关的现金92,620,020.7791,745,891.7393,290,782.545,704,585.21
  筹资活动现金流出小计229,807,502.38224,300,382.61103,995,214.11213,926,918.12
  筹资活动产生的现金流量净额-142,651,184.41-152,144,064.64-42,890,914.11-174,176,918.12
四、汇率变动对现金及现金等价物的影响-2,566.09-441.85-745.47
五、现金及现金等价物净增加额-367,922,167.95-366,389,011.3756,807,773.04-345,000,137.34
  加:期初现金及现金等价物余额1,595,165,053.711,595,165,053.711,595,165,053.711,940,165,191.05
  期末现金及现金等价物余额1,227,242,885.761,228,776,042.341,651,972,826.751,595,165,053.71
补充资料:
  净利润-345,337,466.37-185,960,824.83
  资产减值准备-16,435,037.58-15,251,452.39
  固定资产和投资性房地产折旧-33,682,424.91-67,429,651.43
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-33,682,424.91-67,429,651.43
  无形资产摊销-4,085,575.62-10,856,123.58
  长期待摊费用摊销-195,215.94-29,155.84
  处置固定资产、无形资产和其他长期资产的损失-2,244,788.65-45,791.66
  固定资产报废损失----95,335.55
  公允价值变动损失-197,794.77--2,899,993.92
  财务费用-1,284,520.32-3,134,711.67
  投资损失--315,674,594.19--100,178,648.73
  递延所得税----3,771,989.79
  其中:递延所得税资产减少----2,364,114.91
    递延所得税负债增加----1,407,874.88
  存货的减少--2,650,403.49--21,715,981.66
  经营性应收项目的减少--29,321,854.53--42,561,425.06
  经营性应付项目的增加-11,867,838.06--31,658,389.24
  其他---5,551,366.68
  现金的期末余额-1,228,776,042.34-1,595,165,053.71
  减:现金的期初余额-1,595,165,053.71-1,940,165,191.05
  现金及现金等价物的净增加额--366,389,011.37--345,000,137.34
公告日期2025-10-242025-08-222025-04-252025-03-21
审计意见(境内)标准无保留意见
TOP↑